Estee Lauder Companies Inc vs 10X Genomics Inc — how do they compare? Estee Lauder Companies Inc trades at $88.01 (market cap $31.76B), while 10X Genomics Inc trades at $58.7 (market cap $7.61B). The key difference: Estee Lauder Companies Inc is far larger — about 4.2× 10X Genomics Inc's market cap, and Estee Lauder Companies Inc pays a 1.59% dividend while 10X Genomics Inc pays none. Which is the better fit depends on your goals.
| EL | TXG | |
|---|---|---|
Market Cap | $31.76B | $7.61B |
Sector | Consumer Staples | Health |
52-Week High | $119.61 | $58.57 |
52-Week Low | $67.23 | $11.34 |
Enterprise Value | $37.93B | $7.14B |
Dividend Yield | 1.59% | — |
Trailing returns across standard periods
Estee Lauder is the world leader in the global prestige beauty market, participating across skincare (56% of fiscal 2022 sales), makeup (26%), fragrance (14%), and haircare (4%) categories, with popular brands such as Estee Lauder, Clinique, MAC, La Mer, Jo Malone, Aveda, Bobbi Brown, Too Faced, Origins, Dr. Jart+, and The Ordinary. The firm operates in 150 countries, with 26% of fiscal 2022 revenue stemming from the Americas, 43% from Europe, the Middle East, and Africa, and 31% from Asia-Pacific. The company sells its products through department stores, travel retail, multi-brand specialty beauty stores, brand-dedicated freestanding stores, e-commerce, salons/spas, and perfumeries.
Read more on EL →10x Genomics Inc is a life science technology company based in the United States. Its solutions include instruments, consumables, and software for analyzing biological systems. The product portfolio of the company includes Chromium Controller, Reagent Kits, 10x Compatible Products, and Informatics Software among others. The majority of its revenue is generated from consumables.
Read more on TXG →